US stock futures are mixed in Monday's premarket session as investors hope to reverse last week losses during the holiday-shortened week.

The Dow Jones Industrial Average futures were down 0.2%, S&P 500 futures were edging 0.1% higher, and Nasdaq futures were rising 0.4%.

Oil prices were moving lower, with front-month global benchmarks Brent crude and West Texas Intermediate crude declining 0.5% and 0.5% respectively.

Later in the morning, non-profit research group the Conference Board will announce the latest reading of its consumer confidence index for December, which is expected to rise to 112.9 from 111.7 the previous month, according to Bloomberg.

In equities, shares of Traws Pharma (TRAW) soared 91% in the premarket session after it said Monday that a phase 1 clinical trial demonstrated the safety and tolerability of tivoxavir marboxil to treat H5N1 bird flu. Phio Pharmaceuticals' (PHIO) stock jumped 68%, following a 1.2% gain on Friday. And Rumble (RUM) shares surged 46% after it said late Friday that it has agreed to a $775 million strategic investment from cryptocurrency firm Tether.

On the losing side, shares of Mistras Group (MG) tumbled 21% after rising 0.9% on Friday. Design Therapeutics (DSGN) stock shed 12% following a 4.3% gain the previous session. And shares of Psyence Biomedical (PBM) fell 16%, eating into Friday's 29% gain.